We conducted tumor treatment-related immune cell and Th1/Th2 subset detection in the patient, comparing the concentrations of 6 cytokines (IL-2, IL-4, IL-6, IL-10, TNF-α, and TNF-γ) and various immune cells in peripheral blood before and after treatment. The gene discussed is IL2; the disease is neoplasm.